Physician

Jack E. Saux, MD

According to 2025 Medicare claims, Jack Saux, MD (NPI: 1528023843) practices hematology/oncology in the Slidell-Mandeville-Covington, LA market, with the plurality of this provider's patient population coming from St. Tammany, LA. This provider's primary affiliated billing organization is MARY BIRD PERKINS CANCER CENTER (NPI: 1295833580; TIN: 237010520) and primary practice location at 70433-3661.

Saux's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 494 traditional Medicare patients, billed 238,778 HCPCS/CPT codes, and received $4,049,413 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,890 prescription claims across 335 beneficiaries totaling $5,408,266 in drug costs, led by Ibrance (Palbociclib). DME data shows 71 claims. Open Payments data shows 140 records totaling $3,101. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $127,420 to $4,049,413. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,518,566 to $5,408,266. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $4,918 to $391.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	468	1,826	$127,420
2016	592	2,069	$142,258
2017	562	2,060	$135,061
2018	462	1,333	$99,195
2019	164	299	$23,889
2020	663	2,588	$191,904
2021	569	124,544	$2,891,943
2022	648	293,285	$5,897,175
2023	560	271,627	$5,400,112
2024	494	238,778	$4,049,413

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	350	2,714	$1,518,566
2016	346	2,626	$1,376,730
2017	350	2,240	$1,484,453
2018	369	2,037	$2,636,457
2019	301	1,729	$4,182,980
2020	283	1,515	$4,605,323
2021	250	1,089	$3,239,960
2022	363	1,767	$4,071,246
2023	376	1,960	$4,005,115
2024	335	1,890	$5,408,266

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	35	129	$67,958
2016	N/R	78	$22,800
2017	N/R	79	$16,436
2018	28	133	$14,496
2019	N/R	87	$6,635
2020	N/R	48	$4,408
2021	N/R	50	$2,760
2022	N/R	14	$1,283
2023	N/R	37	$2,264
2024	N/R	71	$3,324

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	221	995	$126
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	248	377	$86
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	67	237	$41
96372	Injection of drug or substance under skin or into muscle	69	587	$10
36415	Insertion of needle into vein for collection of blood sample	321	1,646	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	43	1,204	$715,037
Tagrisso	Osimertinib Mesylate	37	1,110	$577,081
Imbruvica	Ibrutinib	26	732	$381,916
Revlimid	Lenalidomide	22	667	$345,504
Calquence	Acalabrutinib Maleate	33	990	$323,329

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4414	Ostomy skin barrier, with flange (solid, flexible or accordion), without built-in convexity, 4 x 4 inches or smaller, each	N	N/R	16	$1,894
J8700	Temozolomide, oral, 5 mg	N	N/R	12	$551
A5063	Ostomy pouch, drainable; for use on barrier with flange (2 piece system), each	N	N/R	12	$347
A4406	Ostomy skin barrier, pectin-based, paste, per ounce	N	N/R	12	$294
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	19	$238

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	140	$3,101	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jack E. Saux, MD?

Tedicare shows public-source Medicare data for Jack E. Saux, MD (NPI 1528023843), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jack E. Saux, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jack E. Saux, MD?

Jack E. Saux, MD is linked to MARY BIRD PERKINS CANCER CENTER (billing NPI 1295833580) in the available physician profile data.

Does Jack E. Saux, MD have Open Payments data?

Jack E. Saux, MD has 140 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.